Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses
- 2 September 2020
- journal article
- other
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 16 (12) , 2980-2991
Abstract
The deadly pandemic caused by the novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) represents one of the greatest threats humanity has faced in the last century. Infection with this easily transmissible virus can run the gamut from asymptomatic to fatal, and the disease caused by SARS-CoV-2 has been termed Coronavirus Disease 2019 (COVID-19). What little research that has already been conducted implicates pathological responses by the immune system as the leading culprit responsible for much of the morbidity and mortality caused by COVID-19. In this review we will summarize what is currently known about the systemic immune response to SARS-CoV-2 and potential immunotherapeutic approaches.Keywords
This publication has 128 references indexed in Scilit:
- Making Sense of the Cytokine Storm: A Conceptual Framework for Understanding, Diagnosing, and Treating Hemophagocytic SyndromesPediatric Clinics of North America, 2012
- JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated DiseaseImmunity, 2012
- Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and ImmunityImmunity, 2011
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptorsNature Immunology, 2010
- The Chemokine Receptor CCR5 Plays a Key Role in the Early Memory CD8+ T Cell Response to Respiratory Virus InfectionsImmunity, 2008
- Human immunopathogenesis of severe acute respiratory syndrome (SARS)Virus Research, 2008
- SARS coronavirus and innate immunityVirus Research, 2008
- SARS-coronavirus replication in human peripheral monocytes/macrophagesVirus Research, 2005
- Plasma inflammatory cytokines and chemokines in severe acute respiratory syndromeClinical and Experimental Immunology, 2004
- Control of apoptosis by p53Oncogene, 2003